Search research articles
Contact Us
Filters
Showing results (31-40 of 33) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 33 results.
The Lancet. Neurology
|
March 20, 2021
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
John W Day, Richard S Finkel, Claudia A Chiriboga, et al.
The New England Journal of Medicine
|
November 2, 2017
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
Jerry R Mendell, Samiah Al-Zaidy, Richard Shell, et al.
Neurology
|
October 19, 2012
Prospective cohort study of spinal muscular atrophy types 2 and 3
Petra Kaufmann, Michael P McDermott, Basil T Darras, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 33) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 33 results.
The Lancet. Neurology
|
March 20, 2021
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
John W Day, Richard S Finkel, Claudia A Chiriboga, et al.
The New England Journal of Medicine
|
November 2, 2017
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
Jerry R Mendell, Samiah Al-Zaidy, Richard Shell, et al.
Neurology
|
October 19, 2012
Prospective cohort study of spinal muscular atrophy types 2 and 3
Petra Kaufmann, Michael P McDermott, Basil T Darras, et al.
Page
of 4